Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer

University Hospital, Strasbourg, France

Status: Unknown

Conditions: Breast Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT03580837

6788

Details and patient eligibility

About

The aim of this retrospective study is to evaluate the value of pre-treatment and post-treatment multimodality MRI study, including quantitative evaluation of background parenchymal enhancement, for response prediction and evaluation. This study will include 100 patients treated in a single institution between 2011 and 2016

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients
• Patients with breast cancer treated with neoadjuvant chemotherapy
• Patients with pre- and post-chemotherapy MRI
• Patients who have given their agreement to use their data for research purposes.

Exclusion criteria

• Refusal to participate in the study